Treatment of Latent Tuberculosis Infection: Renewed Opportunity for Tuberculosis Control
Open Access
- 1 July 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (1) , 120-124
- https://doi.org/10.1086/313891
Abstract
New recommendations for targeted tuberculin testing and treatment of latent tuberculosis (TB) infection have recently been published. Changes in nomeKeywords
This publication has 20 references indexed in Scilit:
- Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized TrialJAMA, 2000
- Twice weekly tuberculosis preventive therapy in HIV infection in ZambiaAIDS, 1998
- Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infectionThe Lancet, 1998
- A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1997
- A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for TuberculosisNew England Journal of Medicine, 1997
- Isoniazid preventive therapy for tuberculosis in HIV-1-infected adultsAIDS, 1997
- Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.American Journal of Respiratory and Critical Care Medicine, 1994
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993
- Isoniazid for the Tuberculin Reactor: Take It or Leave ItAmerican Review of Respiratory Disease, 1987
- The Age Threshold for Isoniazid ChemoprophylaxisPublished by American Medical Association (AMA) ,1986